Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
36 Results for "
ubiquitin-like modifier
" in MedChemExpress (MCE) Product Catalog:
Products (36)
36 Results for "ubiquitin-like modifier" in MCE Product Catalog:
2
2 Cited Publications
Cat. No.: HY-P80351
Synonyms: DAP1 antibody;
GAP modifying protein 1 antibody;
GMP 1 antibody;
OFC10 antibody;
PIC 1 antibody;
PIC1 antibody;
SENP2 antibody;
Sentrin 1 antibody;
Sentrin antibody;
Small ubiquitin related modifier 1 antibody;
Small ubiquitin-like modifier 1 antibody;
Small ubiquitin-related modifier 1 antibody;
SMT3 antibody;
SMT3 homolog 3 antibody;
SMT3 suppressor of mif two 3 homolog 1 antibody;
SMT3, yeast, homolog 3 antibody;
Smt3C antibody;
SMT3H3 antibody;
SUMO-1 antibody;
SUMO1 antibody;
SUMO1_HUMAN antibody;
ubiquitin homology domain protein PIC1 antibody;
ubiquitin like 1 antibody;
ubiquitin like protein SMT3C antibody;
ubiquitin like protein UBL1 antibody;
ubiquitin-homology domain protein PIC1 antibody;
ubiquitin-like protein SMT3C antibody;
ubiquitin-like protein UBL1 antibody;
UBL 1 antibody;
UBL1 antibody
2
2 Cited Publications
Cat. No.: HY-P74485
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: UBA1; ubiquitin like modifier Activating Enzyme 1; A1S9T; UBE1; GXP1; ubiquitin‑like modifier‑Activating Enzyme 1; ubiquitin‑Activating Enzyme E1; CFAP124; UBE1X; POC20; ubiquitin‑Activating Enzyme E1 (A1S9T And BN75 Temperature Sensitivity Complementing)
Species:
Human
Source:
Sf9 insect cells
1
1 Cited Publications
Target:
Research Areas:
SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancement .
Target:
Research Areas:
SENP1-IN-3 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 17. SENP1-IN-3 is developed for tumor radiosensitivity enhancement .
Cat. No.: HY-E70372
CAS No.: 1607459-82-4
Target:
Research Areas:
SUMO Protease is highly specific for proteins containing small ubiquitin-like modifier (SUMO) tags. SUMO Protease can be used to regulates the proteins splicing, controlls protein structure and function in vitro .
Target:
Research Areas:
SENP1-IN-4 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 21. SENP1-IN-4 is developed for tumor radiosensitivity enhancement .
Cat. No.: HY-178458
Target:
Research Areas:
UBA5-IN-2 (Compound 50) is a potent ubiquitin-like modifier activating enzyme 5 (UBA5) inhibitor (IC50=0.063 μM). UBA5-IN-2 is promising for research of cancers and protein homeostasis-related diseases .
Cat. No.: HY-134595
CAS No.: 2416910-70-6
Target:
Research Areas:
SENP1-IN-2 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 30. SENP1-IN-2 is developed for tumor radiosensitivity enhancement .
Cat. No.: HY-P703284
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ATG7; HAGP7; Prev. APG7L; ubiquitin-like modifier-Activating Enzyme Atg7; ubiquitin-like modifier-Activating Enzyme ATG7; APG7 Autophagy 7-like (S. Cerevisiae); ubiquitin-Activating Enzyme E1-like Protein; APG7 Autophagy 7-like; ATG12-Activating Enzyme E1
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P703607
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: UBA2; SAE2; UBLE1B; HRIHFB2115; SUMO-activating enzyme subunit 2; EC 2.3.2.-; Anthracycline-associated resistance ARX; ubiquitin-like 1-activating enzyme E1B; ubiquitin-like modifier-activating enzyme 2
Species:
Human
Source:
E. coli
Cat. No.: HY-P702947
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: UBA2; SAE2; UBLE1B; HRIHFB2115; SUMO-activating enzyme subunit 2; EC 2.3.2.-; Anthracycline-associated resistance ARX; ubiquitin-like 1-activating enzyme E1B; ubiquitin-like modifier-activating enzyme 2
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P703608
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: UBA2; SAE2; UBLE1B; HRIHFB2115; SUMO-activating enzyme subunit 2; EC 2.3.2.-; Anthracycline-associated resistance ARX; ubiquitin-like 1-activating enzyme E1B; ubiquitin-like modifier-activating enzyme 2
Species:
Human
Source:
E. coli
Cat. No.: HY-P87316
Synonyms: HSMT3 antibody; MGC117191 antibody; OTTHUMP00000115275 antibody; OTTHUMP00000115276 antibody; OTTHUMP00000115277 antibody; Sentrin 2 antibody; Small ubiquitin like modifier 2 antibody; Small ubiquitin related modifier 2 antibody; small ubiquitin-like modifier 3 antibody; small ubiquitin-related modifier 3 antibody
Cat. No.: HY-P71346
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SUMO3; SMT3 Suppressor Of Mif Two 3 Homolog 1; Prev. SMT3H1; Small ubiquitin-Related modifier 2; SMT3A; ubiquitin-like Protein SMT3B; Small ubiquitin-Related modifier 3; ubiquitin-like Protein SMT3A; SUMO-3; SMT3 Homolog 1; SMT3 Suppressor Of Mif Two 3 Ho
Species:
Human
Source:
HEK293
Cat. No.: HY-P80905
Synonyms: SUMO1; SMT3C; SMT3H3; UBL1; OK/SW-cl.43; Small ubiquitin-related modifier 1; SUMO-1; GAP-modifying protein 1; GMP1; SMT3 homolog 3; Sentrin; ubiquitin-homology domain protein PIC1; ubiquitin-like protein SMT3C; Smt3C; ubiquitin-like protein
Cat. No.: HY-P86396
Synonyms: SUMO1; SMT3C; SMT3H3; UBL1; OK/SW-cl.43; Small ubiquitin-related modifier 1; SUMO-1; GAP-modifying protein 1; GMP1; SMT3 homolog 3; Sentrin; ubiquitin-homology domain protein PIC1; ubiquitin-like protein SMT3C; Smt3C; ubiquitin-like protein
Cat. No.: HY-P80905A
Synonyms: SUMO1; SMT3C; SMT3H3; UBL1; OK/SW-cl.43; Small ubiquitin-related modifier 1; SUMO-1; GAP-modifying protein 1; GMP1; SMT3 homolog 3; Sentrin; ubiquitin-homology domain protein PIC1; ubiquitin-like protein SMT3C; Smt3C; ubiquitin-like protein
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
